Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (389)	1/3/1999 8:24:00 PM
From: cm	Respond to of 1386

Hardly small-minded, NeuroInvestment... and duly noted <eom>

To: NeuroInvestment who wrote (389)	1/3/1999 8:29:00 PM
From: crysball	Respond to of 1386

Neuroinvestor, It is very difficult to due 'all the due diligence and research' on the origin of commnets appearing on this message board, but I wholeheartedly concur the originator should be fully credited. While not a current subscriber to Neuroinvestor I would appreciate your insight into the impact of fast track on HU211 and PARS, or perhaps more succinctly, if you were CEO of PARS how would this affect your timing and strategy in finding a strategic partnetr for HU211?